Obesity phenotypes and their paradoxical association with cardiovascular diseases A Vecchié, F Dallegri, F Carbone, A Bonaventura, L Liberale, ... European journal of internal medicine 48, 6-17, 2018 | 304 | 2018 |
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ... The Lancet Oncology 22 (11), 1507-1517, 2021 | 247 | 2021 |
Epicardial adipose tissue and cardiovascular diseases AM Ansaldo, F Montecucco, A Sahebkar, F Dallegri, F Carbone International journal of Cardiology 278, 254-260, 2019 | 210 | 2019 |
Pathophysiological role of neutrophils in acute myocardial infarction F Carbone, A Nencioni, F Mach, N Vuilleumier, F Montecucco Thrombosis and haemostasis 110 (09), 501-514, 2013 | 210 | 2013 |
Update on inflammatory biomarkers and treatments in ischemic stroke A Bonaventura, L Liberale, A Vecchié, M Casula, F Carbone, F Dallegri, ... International journal of molecular sciences 17 (12), 1967, 2016 | 181 | 2016 |
Impact of different ectopic fat depots on cardiovascular and metabolic diseases D Ferrara, F Montecucco, F Dallegri, F Carbone Journal of cellular physiology 234 (12), 21630-21641, 2019 | 177 | 2019 |
Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments F Montecucco, F Carbone, TH Schindler European heart journal 37 (16), 1268-1283, 2016 | 159 | 2016 |
Prognostic value of PCSK9 levels in patients with acute coronary syndromes B Gencer, F Montecucco, D Nanchen, F Carbone, R Klingenberg, ... European Heart Journal 37 (6), 546-553, 2016 | 158 | 2016 |
Novel findings in neutrophil biology and their impact on cardiovascular disease A Bonaventura, F Montecucco, F Dallegri, F Carbone, TF Lüscher, ... Cardiovascular Research 115 (8), 1266-1285, 2019 | 143 | 2019 |
The role of inflammation in cardiovascular outcome F Montecucco, L Liberale, A Bonaventura, A Vecchiè, F Dallegri, ... Current atherosclerosis reports 19, 1-9, 2017 | 132 | 2017 |
Apomorphine for Parkinson’s disease: efficacy and safety of current and new formulations F Carbone, A Djamshidian, K Seppi, W Poewe CNS drugs 33, 905-918, 2019 | 128 | 2019 |
The pathophysiological role of neutrophil extracellular traps in inflammatory diseases A Bonaventura, L Liberale, F Carbone, A Vecchié, C Diaz-Cañestro, ... Thrombosis and haemostasis 118 (01), 006-027, 2018 | 128 | 2018 |
Regulation and function of extracellular nicotinamide phosphoribosyltransferase/visfatin F Carbone, L Liberale, A Bonaventura, A Vecchiè, M Casula, M Cea, ... Comprehensive Physiology 7 (2), 603-621, 2011 | 117 | 2011 |
Update on cardiotoxicity of anti‐cancer treatments GM Rosa, L Gigli, MI Tagliasacchi, C Di Iorio, F Carbone, A Nencioni, ... European journal of clinical investigation 46 (3), 264-284, 2016 | 103 | 2016 |
The role of adipocytokines in coronary atherosclerosis L Liberale, A Bonaventura, A Vecchiè, C Matteo, F Dallegri, F Montecucco, ... Current atherosclerosis reports 19, 1-12, 2017 | 100 | 2017 |
Pathophysiological relevance of macrophage subsets in atherogenesis L Liberale, F Dallegri, F Montecucco, F Carbone Thrombosis and haemostasis 26 (01), 07-18, 2017 | 97 | 2017 |
Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases M Casula, F Montecucco, A Bonaventura, L Liberale, A Vecchié, ... Vascular pharmacology 99, 1-12, 2017 | 87 | 2017 |
Non‐motor symptoms in Parkinson's disease are reduced by nabilone M Peball, F Krismer, HG Knaus, A Djamshidian, M Werkmann, F Carbone, ... Annals of neurology 88 (4), 712-722, 2020 | 85 | 2020 |
Potential pathophysiological role for the vitamin D deficiency in essential hypertension F Carbone, F Mach, N Vuilleumier, F Montecucco World journal of cardiology 6 (5), 260, 2014 | 78 | 2014 |
Neurological outcomes 1 year after COVID‐19 diagnosis: A prospective longitudinal cohort study V Rass, R Beer, AJ Schiefecker, A Lindner, M Kofler, BA Ianosi, ... European journal of neurology 29 (6), 1685-1696, 2022 | 76 | 2022 |